ライフサイエンスコーパス: N-ethylmaleimide

1 ysteines by oxidation and reaction with NEM (N-ethylmaleimide).

2 y blocking the S-nitrosylation reaction with N-ethylmaleimide.

3 nd to be predominantly modified by thiols or N-ethylmaleimide.

4 ide-sensitive factor attachment protein, and N-ethylmaleimide.

5 S-nitrosoglutathione, hydrogen peroxide, or N-ethylmaleimide.

6 reatment of cells with low concentrations of N-ethylmaleimide (10 microM), suggesting that enrichment

7 N-Ethylmaleimide, (2-aminoethyl)-methane thiosulfonate,

8 ize the newly formed intermediate selenol by N-ethylmaleimide; (3) deproteinization.

9 Pretreatment with N-ethylmaleimide, a small, membrane-permeating compound

10 activity, and the activity was sensitive to N-ethylmaleimide, a sulfhydryl-modifying reagent.

11 Cys in the D'D3 monomer were alkylated with N-ethylmaleimide and analyzed by mass spectrometry.

12 tosol-dependent fashion that is sensitive to N-ethylmaleimide and dependent on Sar1 and sec22B.

13 >10-kDa molecular mass that is resistant to N-ethylmaleimide and heat inactivation.

14 was prevented by the SNARE protein inhibitor N-ethylmaleimide and the calcium chelator BAPTA.

15 ne residues to the membrane-permeant reagent N-ethylmaleimide and the membrane-impermeant reagent pol

16 N-Ethylmaleimide and thimerosal were able to simulate th

17 hibited by sodium vanadate, sodium fluoride, N-ethylmaleimide, and phenylglyoxal but was not signific

18 nt species are trapped by cycloaddition with N-ethylmaleimide, and the reactions are traced by high r

19 have been shown to be covalently modified by N-ethylmaleimide, and this treatment was found to block

20 ions for activity, was potently inhibited by N-ethylmaleimide, and was labile at temperatures above 4

21 of UL16 would be expected to be modified by N-ethylmaleimide, and, consistent with this, the amount

22 Furthermore, both N-ethylmaleimide- and H(2)O(2)-induced TRPC6 activations

23 al calcium-dependent Syt1 binding to soluble N-ethylmaleimide attachment protein receptor (SNARE) and

24 tion of Gbetagamma subunits with the soluble N-ethylmaleimide attachment protein receptor (SNARE) com

25 Although FAK inhibition decreased soluble N-ethylmaleimide attachment protein receptor (SNARE)-med

26 6, a Golgi-localized target membrane-soluble N-ethylmaleimide attachment protein receptor (t-SNARE) p

27 onylation were specifically derivatized with N-ethylmaleimide-biotin.

28 lent modification of its free cysteines with N-ethylmaleimide blocked binding to UL11 but not UL21.

29 y the membrane-permeable sulfhydryl blocker, N-ethylmaleimide, by the RGD peptide, and by anti-alphaI

30 Preventing RyR cross-linking with N-ethylmaleimide decreased the propensity of Ca(2+) wave

31 modification of free cysteines in UL16 with N-ethylmaleimide does in fact prevent binding.

32 ined the role of a vesicle-residing, soluble N-ethylmaleimide factor attachment protein receptor (v-S

33 afficking proteins including SNAREs (soluble N-ethylmaleimide factor attachment protein receptors) an

34 r semolina protein (g protein) or 13.8 mumol N-ethylmaleimide/g protein reduces gliadin-glutenin cros

35 ectrometry after derivatization to yield GSH-N-ethylmaleimide (GSNEM).

36 In all cases, pretreatment with vanadate or N-ethylmaleimide inhibited the conversion of echinocytes

37 of the completely conserved Cys353) through N-ethylmaleimide modification or mutagenesis to alanine

38 to (2-aminoethyl)-methane thiosulfonate and N-ethylmaleimide modification.

39 ble redox states of both the as purified and N-ethylmaleimide-modified forms, using the combination o

40 tment of muscle cells with the NSF inhibitor N-ethylmaleimide, mutation of NSF, or suppression of NSF

41 Sensitivity to N-ethylmaleimide (NEM) and methanethiosulfonate reagents

42 that was inhibited by the vesicle inhibitors N-ethylmaleimide (NEM) and monensin.

43 Chemical labeling with N-ethylmaleimide (NEM) and tandem mass spectrometry expe

44 odification by the membrane permeant reagent N-ethylmaleimide (NEM) and the membrane impermeant reage

45 we have investigated the mechanism by which N-ethylmaleimide (NEM) enhances transporter activity usi

46 n erythrocytes, the cysteine-modifying agent N-ethylmaleimide (NEM) has been shown to inhibit system

47 ng of the protein thiol groups on the MPI by N-ethylmaleimide (NEM) markedly reduced this rate consta

48 ions isolated in the presence and absence of N-ethylmaleimide (NEM), a chemical that reacts irreversi

49 e rate and effect of Cys-159 modification by N-ethylmaleimide (NEM), a cysteine-selective alkylating

50 pyridine, a known Isomerase I inhibitor, and N-ethylmaleimide (NEM), a known LRAT inhibitor, signific

51 N-ethylmaleimide (NEM), and to a lesser extent, dithio(b

52 nalytes ((310)GSH and (616)GSSG), along with N-ethylmaleimide (NEM), and treated with acetonitrile to

53 was cGMP independent but could be blocked by N-ethylmaleimide (NEM), indicating that NO acted via an

54 Pretreatment with N-ethylmaleimide (NEM), which occludes S-nitrosylation,

55 the unmodified free thiols are blocked using N-ethylmaleimide (NEM).

56 rbation by treatment with the thiol reagent, N-ethylmaleimide (NEM).

57 were more modest with a slight inhibition in N-ethylmaleimide (NEM, 1 mm)-treated RBCs and stimulatio

58 by (2-aminoethyl)-methane thiosulfonate and N-ethylmaleimide of cysteine mutant proteins were measur

59 ovalent thiol modification of reduced PDI by N-ethylmaleimide or methyl-methanethiosulfonate, which a

60 chemical labeling by isotope-coded forms of N-ethylmaleimide or succinic anhydride to site-specifica

61 ydes (c = 8 mmol L(-1)), photoligations with N-ethylmaleimide (possible for lambda </= 390 nm) are id

62 above their optimums and by Ca(2+), Zn(2+), N-ethylmaleimide, propranolol, and the sphingoid bases s

63 inganine) lipids, nucleotides (ATP and CTP), N-ethylmaleimide, propranolol, phenylglyoxal, and divale

64 of reactive electrophiles: glyoxalase I and N-ethylmaleimide reductase.

65 -saturating concentrations of the activator, N-ethylmaleimide-S1.

66 ld-type at near-saturating concentrations of N-ethylmaleimide-S1.

67 e release machinery, this assay incorporates N-ethylmaleimide sensitive factor (NSF) and alpha-SNAP,

68 olecule binds our two model His(6) proteins, N-ethylmaleimide sensitive factor (NSF) and O(6)-alklygu

69 Moreover, we provided evidence for a role of N-ethylmaleimide sensitive factor (NSF) in regulating Mu

70 y related to the single N domains in p97 and N-ethylmaleimide sensitive factor (NSF); N1 of Pex1 is m

71 We find that lotus encodes N-ethylmaleimide sensitive factor 2 (NSF2), whereas whee

72 ction, enabling cooperation with the soluble N-ethylmaleimide sensitive factor adaptor protein recept

73 t significantly reduced formation of soluble n-ethylmaleimide sensitive factor adaptor protein recept

74 Phosphorylation of this t-soluble N-ethylmaleimide sensitive factor attachment protein rec

75 tinct combinations of Munc18 and the soluble N-ethylmaleimide sensitive factor attachment protein rec

76 gmin, complexin, and neuronal SNARE (soluble N-ethylmaleimide sensitive factor attachment protein rec

77 Sec1/Munc18 (SM) proteins and soluble N-ethylmaleimide sensitive factor attachment protein rec

78 Soluble N-ethylmaleimide sensitive factor attachment protein rec

79 rt a role for tethering complexes in soluble N-ethylmaleimide sensitive factor attachment protein rec

80 domain, which likely participates in soluble N-ethylmaleimide sensitive factor attachment protein rec

81 Evolutionarily conserved SNARE (soluble N-ethylmaleimide sensitive factor attachment protein rec

82 taining lipid bilayers as well as to soluble N-ethylmaleimide sensitive factor receptors (SNAREs) and

83 N-Ethylmaleimide sensitive factor recycles SNAREs after

84 The ATPase NSF (N-ethylmaleimide sensitive factor), together with SNAPs

85 The exocytic vesicular soluble N-ethylmaleimide sensitive fusion protein attachment pro

86 Whereas SNARE (soluble N -ethylmaleimide-sensitive factor attachment protein re

87 by the packaging of a SNARE protein (soluble N-ethylmaleimide-sensitive attachment protein receptor)

88 vity to tomosyn that are outside the soluble N-ethylmaleimide-sensitive attachment receptor motif.

89 ty on secretion without altering its soluble N-ethylmaleimide-sensitive attachment receptor pairing w

90 18-1 (stabilizes assembled SNARE complexes), N-ethylmaleimide-sensitive factor (NSF) (disassembles SN

91 The time at which the N-ethylmaleimide-sensitive factor (NSF) acts during syna

92 A soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

93 ly AAA domain-containing protein 1), soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

94 Soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

95 Soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

96 t is directly involved in regulating soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

97 domain and modulate the affinity for soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

98 isoforms to directly regulate SNARE (soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

99 In eukaryotic cells, the soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

100 Sec17 [soluble N-ethylmaleimide-sensitive factor (NSF) attachment prote

101 N-Ethylmaleimide-sensitive factor (NSF) is a homo-hexame

102 daptor molecule for the SNARE-priming enzyme N-ethylmaleimide-sensitive factor (NSF) is known to be c

103 novel synaptic interaction between Arr1 and N-ethylmaleimide-sensitive factor (NSF) that is enhanced

104 ATPase activity and disassembly activity of N-ethylmaleimide-sensitive factor (NSF), a critical comp

105 inhibits exocytosis by chemically modifying N-ethylmaleimide-sensitive factor (NSF), a key component

106 n kinase Cepsilon (PKCepsilon) regulates the N-ethylmaleimide-sensitive factor (NSF), an ATPase criti

107 The human beta2AR carboxyl end binds to the N-ethylmaleimide-sensitive factor (NSF), an ATPase integ

108 s hepatic secretion of VLDL-TAG by targeting N-ethylmaleimide-sensitive factor (NSF), both in vivo an

109 N-ethylmaleimide-sensitive factor (NSF), first discovere

110 cate a core complex of proteins comprised of N-ethylmaleimide-sensitive factor (NSF), soluble NSF att

111 lex is disassembled by an AAA+ ATPase called N-ethylmaleimide-sensitive factor (NSF).

112 d iPSC-derived human neurons, among them the N-ethylmaleimide-sensitive factor (NSF).

113 KMzeta maintains late-LTP through persistent N-ethylmaleimide-sensitive factor (NSF)/glutamate recept

114 ents, whereas further incubation with p97 or N-ethylmaleimide-sensitive factor (two AAA ATPases invol

115 e presence of LPC as opposed to cholesterol, N-ethylmaleimide-sensitive factor + adenosine triphospha

116 sively to the predicted syntaxin and soluble N-ethylmaleimide-sensitive factor accessory protein rece

117 Soluble N-ethylmaleimide-sensitive factor activating protein rec

118 lar C-terminus domain and the SNARE (soluble N-ethylmaleimide-sensitive factor activating protein rec

119 cer to prevent the completion of the soluble N-ethylmaleimide-sensitive factor activating protein rec

120 am of the Rab GTPase Sec4 to promote soluble N-ethylmaleimide-sensitive factor adaptor protein recept

121 or of the Sec4 Rab GTPase to promote soluble N-ethylmaleimide-sensitive factor adaptor protein recept

122 amined whether genetic disruption of soluble N-ethylmaleimide-sensitive factor attached protein (SNAR

123 The assembly of the three neuronal soluble N-ethylmaleimide-sensitive factor attachment protein (SN

124 Trans-soluble N-ethylmaleimide-sensitive factor attachment protein (SN

125 unc18-like) protein Munc18-1 and the soluble N-ethylmaleimide-sensitive factor attachment protein (SN

126 SNARE) complexes in conjunction with soluble N-ethylmaleimide-sensitive factor attachment protein (SN

127 a (SNAP-25) is a key molecule in the soluble N-ethylmaleimide-sensitive factor attachment protein (SN

128 cognate acceptor compartments before soluble N-ethylmaleimide-sensitive factor attachment protein (SN

129 , which harbors a mutation in Napa [encoding N-ethylmaleimide-sensitive factor attachment protein alp

130 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

131 binds to and cleaves syntaxin 17, a soluble N-ethylmaleimide-sensitive factor attachment protein rec

132 The soluble N-ethylmaleimide-sensitive factor attachment protein rec

133 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

134 erved increase in K(+) currents is a soluble N-ethylmaleimide-sensitive factor attachment protein rec

135 We identified a member of the soluble N-ethylmaleimide-sensitive factor attachment protein rec

136 tether at the plasma membrane before soluble N-ethylmaleimide-sensitive factor attachment protein rec

137 aptic vesicles, including the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

138 litate the formation of trans-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

139 etric levels with its cognate target-soluble N-ethylmaleimide-sensitive factor attachment protein rec

140 rs in membrane fusion events are the soluble N-ethylmaleimide-sensitive factor attachment protein rec

141 Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec

142 es depends on the disassembly of cis-soluble N-ethylmaleimide-sensitive factor attachment protein rec

143 ter release and vesicle recycling in soluble N-ethylmaleimide-sensitive factor attachment protein rec

144 UT4 vesicle fusion reaction requires soluble N-ethylmaleimide-sensitive factor attachment protein rec

145 organelles involves the formation of soluble N-ethylmaleimide-sensitive factor attachment protein rec

146 ructural relationships among SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec

147 at Munc18c binds to the trans-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

148 n fusogens from vesicle trafficking (soluble N-ethylmaleimide-sensitive factor attachment protein rec

149 sis requires the concerted action of soluble N-ethylmaleimide-sensitive factor attachment protein rec

150 existence of the unproductive target soluble N-ethylmaleimide-sensitive factor attachment protein rec

151 proteins are important components of soluble N-ethylmaleimide-sensitive factor attachment protein rec

152 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

153 insulin granules, is carried out by soluble N-ethylmaleimide-sensitive factor attachment protein rec

154 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

155 SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

156 Platelet exocytosis is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec

157 of the fusion pore induced by SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

158 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

159 ere is comparable fusion of 4-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

160 he general membrane fusion machinery-soluble N-ethylmaleimide-sensitive factor attachment protein rec

161 f exocytosis by interacting with the soluble N-ethylmaleimide-sensitive factor attachment protein rec

162 ey synaptic proteins from the soluble SNARE (N-ethylmaleimide-sensitive factor attachment protein rec

163 v2.1 is postulated to be involved in soluble N-ethylmaleimide-sensitive factor attachment protein rec

164 icle marker proteins, glutamate, the soluble N-ethylmaleimide-sensitive factor attachment protein rec

165 labeled vesicle-associated v-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

166 The soluble N-ethylmaleimide-sensitive factor attachment protein rec

167 y and activation of (phago)lysosomal soluble N-ethylmaleimide-sensitive factor attachment protein rec

168 st that syt1 might facilitate SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

169 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

170 mediated by the formation of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

171 ric syntaxin 1A, and it can activate soluble N-ethylmaleimide-sensitive factor attachment protein rec

172 e Arabidopsis (Arabidopsis thaliana) soluble N-ethylmaleimide-sensitive factor attachment protein rec

173 Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein rec

174 -overexpression of ER/Golgi arginine soluble N-ethylmaleimide-sensitive factor attachment protein rec

175 ed components: vacuolar lipids, four soluble N-ethylmaleimide-sensitive factor attachment protein rec

176 by specific fusion proteins [such as soluble N-ethylmaleimide-sensitive factor attachment protein rec

177 udies of membrane fusion mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec

178 wo C2 domains, and the neuronal core soluble N-ethylmaleimide-sensitive factor attachment protein rec

179 oteins that regulate the activity of soluble N-ethylmaleimide-sensitive factor attachment protein rec

180 usion is mediated by the concerted action of N-ethylmaleimide-sensitive factor attachment protein rec

181 activity on one of the three SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

182 ces derived from target- and vesicle-soluble N-ethylmaleimide-sensitive factor attachment protein rec

183 icularly involving small G proteins, soluble N-ethylmaleimide-sensitive factor attachment protein rec

184 ia a Gbetagamma interaction with the soluble N-ethylmaleimide-sensitive factor attachment protein rec

185 c1/Munc18 (SM) proteins bind cognate soluble N-ethylmaleimide-sensitive factor attachment protein rec

186 and botulinum neurotoxin C to cleave soluble N-ethylmaleimide-sensitive factor attachment protein rec

187 with purified yeast vacuolar SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec

188 Yeast vacuole fusion requires soluble N-ethylmaleimide-sensitive factor attachment protein rec

189 mitter release requires three SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

190 which, in turn, interacts with the lysosomal N-ethylmaleimide-sensitive factor attachment protein rec

191 ade transport of the plasma membrane soluble N-ethylmaleimide-sensitive factor attachment protein rec

192 otulinum neurotoxins cleave specific soluble N-ethylmaleimide-sensitive factor attachment protein rec

193 a do not contain the t-SNARE (target-soluble N-ethylmaleimide-sensitive factor attachment protein rec

194 on and vacuole protein sorting), and soluble N-ethylmaleimide-sensitive factor attachment protein rec

195 The soluble N-ethylmaleimide-sensitive factor attachment protein rec

196 -mediated selective concentration of soluble N-ethylmaleimide-sensitive factor attachment protein rec

197 2Delta) for the Tlg2 target membrane-soluble N-ethylmaleimide-sensitive factor attachment protein rec

198 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

199 mediated by syntaxin 4-based SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

200 Although concentrated soluble N-ethylmaleimide-sensitive factor attachment protein rec

201 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

202 e.g., microtubules, the exocyst, and soluble N-ethylmaleimide-sensitive factor attachment protein rec

203 g interaction of Gbetagamma with the soluble N-ethylmaleimide-sensitive factor attachment protein rec

204 out the regulatory roles of specific soluble N-ethylmaleimide-sensitive factor attachment protein rec

205 (GTX), a Drosophila t-SNARE (target-soluble N-ethylmaleimide-sensitive factor attachment protein rec

206 n vitro and to separate the roles of soluble N-ethylmaleimide-sensitive factor attachment protein rec

207 Synaptic soluble N-ethylmaleimide-sensitive factor attachment protein rec

208 nal by cooperating with the neuronal soluble N-ethylmaleimide-sensitive factor attachment protein rec

209 er release requires the formation of soluble N-ethylmaleimide-sensitive factor attachment protein rec

210 11 interact with the vacuolar SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

211 NSF disassembles soluble N-ethylmaleimide-sensitive factor attachment protein rec

212 nner with syntaxin-3 and syntaxin-1A soluble N-ethylmaleimide-sensitive factor attachment protein rec

213 a component of the synaptic vesicle soluble N-ethylmaleimide-sensitive factor attachment protein rec

214 SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

215 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

216 stituted with the target (t)-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec

217 loit a polarized distribution of the soluble N-ethylmaleimide-sensitive factor attachment protein rec

218 gue Dawley rats, 4 dominant-negative soluble N-ethylmaleimide-sensitive factor attachment protein rec

219 iated by the formation of functional soluble N-ethylmaleimide-sensitive factor attachment protein rec

220 s the Rab GTPase Ypt7p, four SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein rec

221 cellular transport vesicles requires soluble N-ethylmaleimide-sensitive factor attachment protein rec

222 h abnormal expression or function of soluble N-ethylmaleimide-sensitive factor attachment protein rec

223 Although epsinR is known to be an N-ethylmaleimide-sensitive factor attachment protein rec

224 vitro by arresting the late steps of soluble N-ethylmaleimide-sensitive factor attachment protein rec

225 o an open conformation to accelerate soluble N-ethylmaleimide-sensitive factor attachment protein rec

226 transmitters and hormones depends on soluble N-ethylmaleimide-sensitive factor attachment protein rec

227 mice expressing a dominant-negative soluble N-ethylmaleimide-sensitive factor attachment protein rec

228 Neuronal exocytosis is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein rec

229 SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

230 Soluble N-ethylmaleimide-sensitive factor attachment protein rec

231 unc13-4 is a Ca(2+)-dependent SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein rec

232 The soluble N-ethylmaleimide-sensitive factor attachment protein rec

233 ent work suggested that ER-localized soluble N-ethylmaleimide-sensitive factor attachment protein rec

234 is depends on efficient formation of soluble N-ethylmaleimide-sensitive factor attachment protein rec

235 Mast cell degranulation requires N-ethylmaleimide-sensitive factor attachment protein rec

236 guanosine 5'-3-O-(thio)triphosphate, soluble N-ethylmaleimide-sensitive factor attachment protein, an

237 nt protein receptor (SNARE) proteins soluble N-ethylmaleimide-sensitive factor attachment protein-25

238 02590 (a predicted alpha-SNAP [alpha-soluble N-ethylmaleimide-sensitive factor attachment protein]).

239 role of the fusion proteins, SNAREs (soluble N-ethylmaleimide-sensitive factor attachment proteins),

240 osine triphosphate-binding proteins, soluble N-ethylmaleimide-sensitive factor attachment proteins, a

241 ocytosis relies on assembly of three soluble N-ethylmaleimide-sensitive factor attachment receptor (S

242 In neurons, soluble N-ethylmaleimide-sensitive factor attachment receptor (S

243 Syntaxin 1a is a plasma membrane soluble N-ethylmaleimide-sensitive factor attachment receptor pr

244 ions homologous to eukaryotic SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor) d

245 Syt 1 using a reconstituted, SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor)-m

246 of tail-anchored proteins, including soluble N-ethylmaleimide-sensitive factor attachment receptors (

247 ndence in the NSF gene, encoding the protein N-Ethylmaleimide-Sensitive Factor essential for synaptic

248 hibiting the binding of SNAREs to Sec18p, an N-ethylmaleimide-sensitive factor homologue responsible

249 Using the trimerized alphaSNAP, we find that N-ethylmaleimide-sensitive factor hydrolyzes 10 ATP mole

250 19712) or by inhibiting exocytosis (TAT-NSF, N-ethylmaleimide-sensitive factor inhibitor).

251 P2;5 are regulated by the SNARE (for soluble N-ethylmaleimide-sensitive factor protein attachment pro

252 SNARE (soluble N-ethylmaleimide-sensitive factor protein attachment pro

253 RE complex is disassembled by the AAA-ATPase N-ethylmaleimide-sensitive factor that requires the cofa

254 The ATPase NSF (N-ethylmaleimide-sensitive factor) and the adaptor prote

255 , an essential component of the soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein re

256 ly of proteins known as SNAREs [soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein re

257 alpha-SNAP [soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein] a

258 SF attachment protein, and NSF is defined as N-ethylmaleimide-sensitive factor) complexes catalyze sy

259 omotypic vesicle fusion by dephosphorylating N-ethylmaleimide-sensitive factor, a key regulator of ve

260 ndent kinase II and the trafficking proteins N-ethylmaleimide-sensitive factor, GABA receptor-associa

261 SNX27-independent recycling may involve N-ethylmaleimide-sensitive factor, which binds both PDZ

262 gral membrane transporters, ATPases, soluble N-ethylmaleimide-sensitive factor-activating protein rec

263 structures, and here we examine the role of N-ethylmaleimide-sensitive factor-activating protein rec

264 The soluble N-ethylmaleimide-sensitive factor-attachment protein rec

265 During synaptic vesicle fusion, the soluble N-ethylmaleimide-sensitive factor-attachment protein rec

266 ogenetic approach to identify target soluble N-ethylmaleimide-sensitive factor-attachment protein rec

267 and retromer and another possibly involving N-ethylmaleimide-sensitive factor.

268 ARE hybrid complex cannot be disassembled by N-ethylmaleimide-sensitive factor.

269 uscular synapses through cleavage of soluble N-ethylmaleimide-sensitive fusion (NSF) attachment prote

270 rement of Ca(2+) for the assembly of soluble N-ethylmaleimide-sensitive fusion attachment protein rec

271 vesicle (DCV) exocytosis is a SNARE (soluble N-ethylmaleimide-sensitive fusion attachment protein rec

272 rylates SNAP-23, the target membrane soluble N-ethylmaleimide-sensitive fusion factor attachment prot

273 In addition, mutation of the N-ethylmaleimide-sensitive fusion protein (NSF) binding

274 We identified a direct interaction between N-ethylmaleimide-sensitive fusion protein (NSF), an ATPa

275 Here we identified Drosophila N-ethylmaleimide-sensitive fusion protein 2 (dNSF2) and

276 Soluble N-ethylmaleimide-sensitive fusion protein attachment pro

277 by integral membrane proteins called soluble N-ethylmaleimide-sensitive fusion protein attachment pro

278 The current model requires soluble N-ethylmaleimide-sensitive fusion protein attachment pro

279 Membrane associated proteins SNAREs (soluble N-ethylmaleimide-sensitive fusion protein attachment pro

280 The soluble N-ethylmaleimide-sensitive fusion protein attachment pro

281 e led to assignments of both vesicle-soluble N-ethylmaleimide-sensitive fusion protein attachment pro

282 Soluble N-ethylmaleimide-sensitive fusion protein attachment pro

283 ons between synaptotagmin and SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment rec

284 , dependent on GluA2 not GluA1, sensitive to N-ethylmaleimide-sensitive fusion protein interaction, a

285 usion requires two AAA ATPases, p97 and NSF (N-ethylmaleimide-sensitive fusion protein), each of whic

286 ns and specific cleavage of neuronal soluble N-ethylmaleimide-sensitive fusion protein-attachment pro

287 vesicles in the brain harbor several soluble N-ethylmaleimide-sensitive-factor attachment protein rec

288 rtery ECs, depletion of Galpha12 and soluble N-ethylmaleimide-sensitive-fusion factor attachment prot

289 Similarly, l-cysteine and N-ethylmaleimide significantly attenuated the inhibition

290 ce, glutathione was derivatized in-situ with N-ethylmaleimide to block the cysteine residue and to en

291 een when HMM was mixed with ATP-insensitive, N-ethylmaleimide-treated HMM (NEM-HMM; 25-30%).

292 The binding of N-ethylmaleimide-treated myosin subfragment 1 (NEM-S1) t

293 s either functionally impaired by trypsin or N-ethylmaleimide treatments or with protein-free liposom

294 the nonspecific small molecule DUB inhibitor N-ethylmaleimide was 16.2+/-3.2 muM and can be used as a

295 The thiol-blocking agent N-ethylmaleimide was applied in order to inhibit formati

296 hibitor (vanadate) and a sulfyhdryl reagent (N-ethylmaleimide) was determined.

297 -aminoethyl methanethiosulfonate, but not by N-ethylmaleimide, was fully protected in the presence of

298 by the kinase inhibitor staurosporine and by N-ethylmaleimide, whereas KCC2(WT), KCC2(T934A), and KCC

299 ation of its only free cysteine residue with N-ethylmaleimide), which causes significant reduction in

300 with either 20mM added NaCl (WPI+NaCl), 5mM N-ethylmaleimide (WPI+NEM) or 20mM added NaCl and 5mM NE